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Accumulating evidence suggests that RNA molecules resides uniquely at a region between nucleotides 1944 and 
can form surfaces that mimic those of proteins. 2002, but reactivity with 18s rRNA has not been reported 
Reactivity of autoantibodies with RNA surfaces may be [3]. Thus, it is clear that autoantibodies recognize and bind 
due to cross-reactivity between a protein epitope and with high specificity to unique and restricted regions of cel- 
the RNA. The structural mimicry detected by an lular RNA molecules in a manner much like their binding 
autoantibody may reflect functional mimicry. to autoepitopes on proteins. 
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Are the epitopes on RNA molecules dependent on the con- 
formation of the RNA? This idea was initially proposed for 
RNA epitopes by Wilusz and Keene [l]. It was later sug- 
gested that stable conformational RNA epitopes probably 
were not involved in interaction of the anticodon region of 
alanine tRNA with autoantibodies in myositis sera 191. 
However, conformational autoimmune RNA epitopes have 
been unequivocally demonstrated to exist within Ul 
snRNA 121, and several other conformational RNA epitopes 
reactive with autoimmune sera have been described (Fig. 1). 
Conformational RNA epitopes (Fig. 1) were discovered 
because autoantibodies in the sera of patients with sys- 
temic autoimmune diseases react directly with discrete 
structural elements in the Ul RNA of the small nuclear 
ribonucleoproteins (snRNPs), transfer RNA (tRNA) and 
ribosomal RNA (rRNA) [l-3]. Such immunoreactivity with 
specific regions of RNA molecules was unexpected, since 
nucleic acids are poorly immunogenic and the net negative 
charge on the surfaces of antibodies generally disfavors 
interactions with the negatively charged phosphate back- 
bones of RNA and DNA. Historically, the reactivity of 
RNA with antibodies has been viewed as a result of acci- 
dental crossreactivity of RNAs with other cellular immuno- 
gens, or from the presentation of RNA fragments to the 
immune system following a breakdown in discrimination 
of self from nonself. But recent data indicate that confor- 
mational RNA epitopes may result from crossreactivity 
between RNAs and proteins that is not merely due to coin- 
cidence [4-71. On the contrary, such RNA epitopes may 
indicate that functional mimicry between proteins and 
RNAs is an important and general biological phenomenon. 
Several of the characteristics of conformational RNA 
epitopes indicate that they may represent meaningful 
structural entities or even biologically interesting sites of 
molecular interaction. For example, autoimmune RNA epi- 
topes are uniquely restricted to certain RNA species. The 
RNA epitopes identified to date are summarized in Figure 
1. Reactive epitopes have been found to reside on the Ul 
small nuclear RNA (snRNA), but not on U2, U3 or any of 
the many other U-rich snRNAs [l]. Certain autoimmune 
patient sera react specifically with initiator methionine 
tRNA (tRNAiMet) [1,8] or alanine tRNA [9], yet other sera 
appear to react with all 4s tRNAs [l,lO,ll]. Autoantibodies 
that react with the hY5 RNA are present in sera of Sjogren’s 
syndrome patients of the autoimmune Ro specificity, but 
reactivity with hY1 through hY4 was not detected [12]. In 
addition, a conformational epitope defined on 285 rRNA 
Why do anti-RNA antibodies arise? 
The existence of sequence-specific conformational auto- 
immune epitopes on cellular RNAs has led to several 
hypotheses to explain their origins. Perhaps the most plau- 
sible of these is that the RNA is carried along during a 
response to a protein. Patients who make autoantibodies to 
the RNA components of RNP particles also generally make 
autoantibodies to at least one of the protein components of 
these particles [13-E], leading to the suggestion that the 
immune system may initially respond to a protein, then 
broaden its response to include the proteins and nucleic 
acids that are tightly associated with the autoantigen. 
The suggestion is reasonable, although not proven, because 
of the manner in which proteinaceous autoantigens are 
believed to be presented to the immune system. Pre-B 
cells, the precursors of antibody-producing cells, express a 
membrane-bound form of antibody (the B-cell receptor) on 
their surface. Particles recognized by the B-cell receptor are 
internalized and processed into fragments, and the peptide 
fragments may then be presented on the surface of the 
pre-B cell, as a complex with class II molecules of the major 
histocompatibility complex (MHC). If an autoreactive 
helper T cell is present that recognizes a peptide derived 
from the RNP complex, the pre-B cell will receive help in 
the form of cytokines such as IL-4, and will differentiate 
into a mature, antibody-producing B cell. 
It is highly unlikely that fragments of RNA molecules can 
be presented on class II MHC molecules in this way, and 
therefore ‘naked’ RNA (or DNA) molecules would not be 
expected to generate an immune response. However, if 
the RNA is bound tightly to a protein autoantigen, a B-cell 
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Figure 1 
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Cellular RNAs reactive with autoimmune sera. Each RNA depicted 
could be immunoprecipitated with sera from autoimmune patients. The 
predicted epitope sequences are indicated for: (a) Ul snRNA 
[1,2,5,17]; (b) initiator methionine transfer RNA [I ,61; (c) alanine 
transfer RNA [9]; (d) hYB-Ro RNA [121; and (e) a portion of human 
26s ribosomal RNA [31. Epitopes (e) in stem II and stem-loop IV of 
Ul snRNA; the anticodon and T regions of transfer RNA(s); the sarcin- 
sensitive site of 26s ribosomal RNA [24,25]; and the stem of hY5 
RNA are highlighted. 
receptor that binds to the RNA may allow the internaliza- 
tion of the whole complex, resulting in presentation of 
peptide fragments of the autoantigen to the autoreactive 
helper T cell and T-cell help for the RNA-binding B cell. 
Cross-reactivity between RNA and protein 
Many other explanations for the generation of antibodies 
that bind to RNA have been suggested, however. In par- 
ticular, several mechanisms for accidental cross-reactivity 
between RNA surfaces and protein surfaces have been 
proposed. According to the idiotypelanti-idiotype hypoth- 
esis, for example, one would expect antibodies to func- 
tion as antigens themselves; anti-antibodies of this kind 
(anti-idiotypes) would have a shape complementary to 
the original antibody, and might therefore mimic the 
shape of the original antigen closely enough to bind to an 
RNA target of the original protein antigen. Extensive 
searches for the idiotypic RNA antibodies in sera from 
autoimmune patients have proved negative (J.D.K., 
unpublished data; [16]). In addition, the RNA epitopes in 
Ul snRNA do not appear to reside in regions of contact 
between RNA-binding proteins and the RNAs [5,12,17]. 
Furthermore, many autoantigenic RNA-binding proteins 
are attached to RNAs for which no anti-RNA antibodies 
have been reported.‘ 
Interestingly, unique RNA molecules can be selected in 
vitro from combinatorial RNA libraries to bind to antibody 
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binding sites [4-71. Could autoimmune RNA epitopes 
represent a similar coincidental binding of cellular RNAs 
to antibodies? One observation which argues against this 
idea is that only a restricted set of cellular RNAs contain 
RNA epitopes. If RNA epitopes occur at random one 
would expect the distribution of epitopes to be more 
uniform among cellular RNAs. For example, one would 
expect to find epitopes on U RNAs other than Ul snRNA. 
One would also expect to find many epitopes in rRNA - 
since it is 20 times the size of Ul snRNA (which contains 
at least 3 such epitopes), there should be in the region of 
60 RNA aptamer-type epitopes in ribosomal RNA, but in 
fact only 1 (or possibly 2) has been reported [3]. Thus, 
coincidence is unlikely to explain the whole phenomenon 
of autoimmune RNA reactivity. Nonetheless, it remains 
possible that certain RNA epitopes present on cellular 
RNAs coincidentally resemble structural features of pro- 
tein antigens. The hypotheses outlined here are not 
necessarily mutually exclusive, of course. 
The ribotope/proteotope hypothesis 
An alternative idea, that at least some antibodies to confor- 
mational RNA epitopes might arise because of crossreac- 
tivity with cellular components that is discrete, specific 
and non-coincidental, arose following the serendipitous 
finding that artificial RNAs can mimic peptide epitopes 
[4]. In an experiment intended to select a preferred RNA 
species for an RNA-binding protein from a degenerate 
RNA library, in which the RNA-binding protein was 
attached to a solid support using an antibody, we instead 
selected an RNA that bound directly to the peptide- 
binding site of the carrier antibody [4]. Because the anti- 
body was originally generated against a 13-amino-acid 
peptide, it appeared that the RNA and the peptide were 
molecular mimics of one another (reviewed in [6]). The 
key evidence suggesting mimicry between these mole- 
cules was that the RNA could compete against the 
peptide for binding to the antibody, and vice versa. Thus, 
these data suggested that an RNA molecule might mimic 
the shape of a protein epitope and thereby occupy a 
similar or overlapping space. It was proposed that autoim- 
mune RNA epitopes might originate by crossreactivity 
with cellular proteins rather than by direct presentation or 
by anti-idiotypic mechanisms [4-61. 
Doudna et al. [7] also demonstrated that an RNA can 
mimic a peptide following in vitro selection against a 
monoclonal antibody to the insulin receptor. This in vitro 
selected RNA also was able to react with autoantibodies 
from patients with extreme insulin resistance and the 
insulin receptor was competitive with the selected RNA 
epitope for binding to the antibody. These findings 
further suggest that RNAs and proteins can recognize 
identical or overlapping topological surfaces on proteins 
(as depicted in Fig. 2) despite the fact that RNA and pro- 
tein are chemically very different and are not expected to 
form the same shapes or to present the same chemical 
moieties on their surfaces. 
If RNA can mimic protein in vitro, can it also do so in 
vivo? Can RNA epitopes bind at sites where protein mol- 
ecules otherwise interact? We have suggested that there 
may be situations in which RNA conformers, called 
ribotopes, can bind to the same target as peptide epitopes 
(proteotopes). Perhaps signals result from the binding of a 
ribotope, or displacement of a proteotope by a ribotope or 
vice versa. Evidence that such mimicry is possible is accu- 
mulating from diverse sources, and it is possible that the 
phenomenon is widespread. 
Sources of proteotopes 
If ribotopes and proteotopes function in a variety of cellular 
processes, polyclonal sera generated by immunization with 
proteotope-containing proteins might help to reveal corre- 
sponding ribotopes. Which cellular proteins contain the pro- 
teotopes that might crossreact with autoimmune ribotopes? 
The autoantigens that provide proteotopes may be the pro- 
teins commonly observed to react with autoimmune sera 
[13-l!?] (ie. primary autoantigens), but are more likely to be 
secondary autoantigens which are less commonly observed. 
In many cases, these autoantigens may not have been iden- 
tified previously. One example of a possible secondary auto- 
antigen discussed below is elongation factor 2 (EF-‘2; EF-G 
in bacteria), which may participate in a tRNA-specific auto- 
immune response. As RNA-specific autoantibodies are gen- 
erally less common than the protein-specific autoantibodies 
and may in some cases appear later in disease progression 
than the protein-specific autoantibodies, the idea that 
secondary autoantigens are the source of proteotopes is 
plausible. Certain crossreactive autoantigenic epitopes may 
be generated by unique proteolytic enzymes involved in 
apoptotic, as well as necrotic degradation [18]. If discrete 
proteotopes can be elucidated, it will be important to deter- 
mine their structures; they may turn out to be presented to 
the immune system in an unusual way. 
Structural mimicry involving conformational RNA epitopes 
The RNA epitopes depicted in Figure 1 were discovered 
over the past decade using sera from patients with autoim- 
mune diseases. It is evident that these epitopes occur in 
regions of the RNAs that involve higher order structures 
and that overlap both paired and unpaired RNA bases. 
tRNA epitopes 
Human autoantibodies generally reactive with 4s RNA 
[ 10,111 and mouse anti-4S antibodies [ 191 have been known 
for some time. However, no specific sequences or structures 
within a given tRNA were found to be immunoreactive 
until tRNAiMef (Fig. 1) was shown to be precipitable using 
sera from patients with Sjogren’s syndrome [l,S]. These 
studies compared the tRNAiMeC sequences of other species 
with those of human and suggested that epitopes reside in 
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Figure 2 
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The ribotopelproteotope model of functional 
mimicry. The antibody with its complementarity 
determining regions (CDRs) is shown at left, 
and the in viva target molecule is shown at 
right, with a similar surface feature to which 
both the RNA ribotope (R) and the protein 
proteotope (P) are able to bind [4-61. The 
molecular shapes of R and P mimic one 
another, allowing binding to the same target 
site. Consequently either molecule may elicit a 
conformational change or functional effect on 
the target molecule. The antibody CDRs are 
formed by antigenic presentation of P which 
results in crossreactivity with R. According to 
this hypothesis, autoantibodies against the 
RNA epitopes shown in Fig. 1 were elicited 
during an autoimmune response to 
autoantigens containing proteotopes, and 
these sera contain antibodies crossreactive 
with the corresponding ribotopes. It is likely 
that only a very small subset of functional 
mimicry of this kind would be detected by 
autoantibodies. 
the anti-codon stem-loop and in the T-stem-loop regions of 
the RNA based upon enzyme protection studies and the 
presence of phylogenetically conserved sequences. Inter- 
estingly, both of these regions, which are highly conserved 
among most species of tRNA, appear (when modeled using 
yeast tRNAPhe) to have similar structures to that of 
Escher&a cofi EF-G [ZO]. This finding is consistent with 
the ribotope/proteotope hypothesis and suggests that 
human EF-2, or a closely related protein (e.g. bacterial 
EF-G itself [21,22]), may be an immunizing antigen, giving 
rise to tRNA-specific autoantibodies in patient sera (Fig. 3, 
highlighted). According to the ribotope hypothesis (Fig. Z), 
one would predict that polyclonal sera reactive with 
autoepitopes on EF-2 might also react with tRNA. It will be 
important to determine whether the antigen must be 
processed in a manner similar to digestion by apoptotic pro- 
teases, thought to produce unique antigenic epitopes in the 
autoimmune response. Likewise, autoimmune patient sera 
reactive with the tRNA epitopes might be reactive with 
EF-2 protein. Therefore, RNA epitopes on the anticodon 
stem-loop of tRNA may represent a topological similarity 
between bacterial and human species, both of which repre- 
sent correspondingly strong homology between bacterial 
EF-G and mammalian EF-2 proteins. A similar analogy can 
be made with the RNA epitope predicted by Sri-Widada et 
al. [8] in the T stem-loop of tRNAiMet (Fig. l), which is 
highly homologous among species. 
rRNA epitopes 
Among the most readily apparent immunoreactive RNAs 
in autoimmune sera is rRNA [1,3,10,13-15,231, which often 
appears as a large smear at the top of acrylamide gels fol- 
lowing immunoprecipitation experiments. Autoantibodies 
reactive with ribosomal RNA, including the 5.8s rRNA [ 11, 
have been known for many years [23] and appear to be 
quite common among serum samples and across disease 
types. Although more than one RNA epitope are probably 
present within 28s rRNA, only one conformational epitope 
(Fig. 1) of apparent biological importance has so far been 
identified [3]. This region of 28s rRNA resides within the 
GTPase center of translation elongation and corresponds to 
residues 1944-2020 in humans. Interestingly, this region is 
nearly identical among metazoans and yeast and is highly 
conserved in prokaryotes. Within this region of bacterial 
23s RNA, which is homologous to the 2% human riboso- 
ma1 RNA epitope, resistance to the antibiotic thiostrepton 
has been shown to result following 2’-0 methylation of a 
critical A residue [24]. Several studies have shown that this 
portion of rRNA in all organisms is involved in elongation 
and GTP hydrolysis when ribosomes translocate from the 
A to the P site of the translation apparatus. By analogy with 
this conformational RNA epitope at 1944-2020 of human 
2% rRNA, the homologous region of bacterial 23s RNA 
binds to EF-G, the bacterial elongation factor analogous to 
EF-2 [ZS]. As noted above, this region of 28s ribosomal 
RNA interacts with the ternary complex consisting of elon- 
gation factors lo, tRNA and GTP and EF-2 in the eukary- 
otic ribosome to form part of the GTPase catalytic center. 
This is the same RNP complex and site of action of RNA 
epitopes in the anticodon arm and in the T arm of tRNA 
(Figs 1,3). Supportive data include the fact that autoanti- 
bodies specific for the 2% RNA epitope at 1944-2020 are 
able to inhibit both GTP hydrolysis and the binding of 
elongation factors to the 80s ribosomal complex [3]. There- 
fore, it is striking that three different conformational RNA 
epitopes reactive with autoantibodies appear to reside 
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Figure 3 
Ribbon diagrams of elongation factor G (left) 
[21,22], tRNAPhe (middle) and the EF-TU 
ternary complex (right) [201, depicting three- 
dimensional structural similarities believed to 
represent functional mimetics [201. 
Sequences in the T stem-loop and in the 
anticodon stem-loop have been implicated 
as conformational RNA epitopes in certain 
tRNAs (see Fig. 1). Note that the tRNAPhe 
represented in the middle structure is 
perpendicular to the page and has a slightly 
different orientation from those of the ternary 
complex and EF-G, which are slightly turned. 
The highlighted regions represent ribotopes 
proposed to result from crossreactivity with 
proteotopes on EF-G (EF-2). 
within the ribonucleoprotein complex and to interact dir- 
ectly with components of the GTPase center which induces 
the translocation step within the translational apparatus. 
Ul snRNA epitopes 
The discovery of epitopes on Ul snRNA (Fig. 1) resulted 
from attempts to immunoprecipitate deproteinized radio- 
labeled RNA from HeLa cells using sera from patients 
with systemic lupus erythematosus (SLE) [l]. These sera 
were known to immunoprecipitate proteins bound to Ul 
snRNP particles [13-151 and some sera were reactive also 
with proteins on other snRNP particles. Following depro- 
teinization and immunoprecipitation, only Ul RNA was 
able to bind to antibodies in these sera. This study found 
that -30 % of the patients with SLE contained Ul 
snRNA-reactive autoantibodies, but their prevalence may 
be higher when more sensitive methods are used. In none 
of these experiments were other uridylate-rich small 
nuclear RNAs, such as U2 through U7, found in the pre- 
cipitated extracts. Thus, the restricted nature of the Ul 
snRNA epitopes is striking. 
Attempts to identify the exact epitopes on the Ul snRNA 
involved the creation of complex pools of partially 
degraded in vitro transcripts followed by immunoprecipita- 
tion and RNA sequencing [Z]. The optimal RNA epitope 
on Ul snRNA appeared to involve -35 nucleotides encom- 
passed within stem-loop II, and an intact stem and loop 
were found to be necessary for antibody reactivity. This 
demonstration of a conformational RNA epitope confirmed 
the previous supposition [l] that autoantibodies react with 
higher order conformers of RNA. Although this study [Z] 
used an iterative procedure involving steps of synthesis, 
immunoprecipitation, sequence identification and resynth- 
esis of deleted variants (outlined in [26]), iterative methods 
were not necessary to isolate the RNA epitopes, as the effi- 
ciency of antibody precipitation is high. These and other 
studies have indicated that the binding specificity and 
affinity of autoantibodies to RNA epitopes is comparable 
to that of proteinaceous antigens. 
Efforts to pinpoint the numbers and locations of RNA epi- 
topes on Ul snRNA have involved systematic deletion 
([2,17]; C.S. Lutz and J.D.K., unpublished data), as well as 
in vitro selection using degenerate pools of synthetic RNA 
transcripts [5,27]. These studies identified at least three 
RNA epitopes located in stem-loop II and one located in 
stem-loop IV of Ul snRNA (Fig. 1). In addition to dele- 
tion analysis, RNAase protection and in vitro selection 
from combinatorial libraries, a variety of RNA competition 
experiments were carried out to confirm the sequence 
requirements for antibody binding to these RNA epitopes 
[5]. These studies were the first to indicate the restri- 
cted nature of the autoimmune response to Ul snRNA 
and demonstrated that multiple epitopes with various 
potential conformations can reside on a single cellular RNA. 
Although candidate proteotopes for the Ul snRNA epi- 
topes have not been identified, autoantibodies specific for 
Ul snRNA should be useful in this search. When the Ul 
snRNP docks with the spliceosome, protein-protein and 
RNA-RNA interactions are known to take place. Contacts 
between Ul snRNA and spliceosomal proteins or between 
Ul snRNP proteins and the pre-mRNA have not been 
reported, but it seems reasonable to suggest that such inter- 
actions occur. If the RNA epitopes on Ul snRNA mimic 
protein epitopes, perhaps the proteins in the splicing 
complex have proteotopes that bind to the same target site 
as the Ul snRNA ribotopes. If so, then the Ul snRNA-spe- 
cific autoantibodies should serve as a useful tool to reveal 
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the proteotope(s), and may even be mimics of the target 
site on the spliceosome. 
hY5 RNA epitope 
Examination of sera from patients with Sjogren’s syn- 
drome and lupus that have the autoimmune Ro specificity 
[13-1.51 found that one of the human Y RNAs is immuno- 
reactive [12]. The lack of autoantibody binding to the 
hYl-hY4 RNAs confirmed the restricted nature of the 
response, but examination of additional sera might yet 
reveal broader reactivity. hY5 RNA is highly structured 
(Fig. 1) and the epitope has been localized to a large 
region in the middle of the molecule encompassing a large 
internal loop. The structural epitopes may be confined to 
a smaller portion of hY5, and it is possible that more than 
one epitope resides in this blocked region. 
Functional mimicry 
As discussed above and depicted in Figure 3, further evi- 
dence of structural mimicry between RNA and protein has 
been provided by the costructure of the ternary complex 
of yeast tRNAPhe bound to elongation factor Tu (EF-Tu) 
from Thermus aquaticus [ZO]. The costructure included the 
GTP nucleotide analog, GDPNP, which was bound to EF- 
Tu in the crystallized complex. One of the striking find- 
ings of this study is that the ternary complex appears to 
resemble the crystal structure of the EF-G from Thermus 
themophihs (analogous to eukaryotic EF-2) whose struc- 
ture with bound GDP was solved previously [21,22]. One 
prediction of the ribotope/proteotope hypothesis is that 
RNA epitopes on tRNA would each have a structurally 
similar protein(s) with which it may crossreact (Fig. 2). 
The findings of Nissen et al. [ZO] are consistent with this 
hypothesis because RNA epitopes have been found in the 
anticodon arm and in the T arm of tRNA [1,8,9], which 
were proposed to have structural mimics on EF-G. Thus, 
it is possible that autoantibodies reactive with these con- 
formational RNA epitopes were originally generated to 
portions of EF-2 (or EF-G) and subsequently crossreacted 
with tRNA. One caveat of the structural mimicry model of 
Nissen et al. [ZO] is that the known structure of EF-G was 
determined in the GDP-bound state, which might differ 
slightly from that of the GTP-bound state. Although there 
are critical functional differences between these nucleo- 
tide-bound states of EF-G, the substitution of GDP for 
GTP may not result in major differences in the regions of 
structural similarity to tRNA in the ternary complex. 
Structural mimicry (Fig. 3) between the ternary complex 
and EF-G [ZO] suggests that they bind to a common target 
site on the ribosome. Both EF-G and the ternary complex 
are involved at the active site of GTP hydrolysis and 
translocation during translation (Fig. 4). This represents a 
key regulatory step in the dynamic transition of amino 
acid addition from the A to the P site of the assembled 
ribosome. Therefore, it is presumed that these similarities 
evolved because of the need for functional mimicry at 
overlapping sites on the ribosome. The autoantibodies 
may be revealing a structural aspect of the mimicry. 
Interestingly, the presence of the 2% RNA epitope (Fig. 
1) at the GTPase center of the ribosome further suggests a 
targeted RNA autoimmune response involving the trans- 
location apparatus (Fig. 4). However, a candidate proteo- 
tope which corresponds to the 28s rRNA epitope has yet 
to be identified, but is predicted to be another proteinac- 
eous surface that interacts at the GTPase center and 
involves the ternary complex and other ribosomal compo- 
nents. The ribotopelproteotope hypothesis would predict 
that the proteotope corresponding to this epitope of 2% 
rRNA might itself be capable of interaction with EF-2 
given that the 28s rRNA epitope is reported to interact 
with this protein. Thus, the autoantibody to the 2% 
ribotope may itself represent a mimic of the EF-2 target 
site for interaction of both the RNA and the protein 
mimetic epitopes. This prediction is speculative, but 
autoantibodies to 2% rRNA should serve as useful 
reagents to dissect interactions within this dynamic region 
of the ribosome and to identify the putative proteotope(s). 
As noted above, autoantibodies to the 2% rRNA epitope 
can inhibit the GTPase and elongation factor binding. It 
will be interesting to determine whether the RNA epi- 
topes revealed on Ul snRNA and on hY.5Ro RNA (Fig. 1) 
are indicators of dynamic trans-acting functions originating 
in these small ribonucleoproteins and competing with pro- 
teins for functions at target sites on larger RNP complexes 
such as the spliceosome. 
Molecular recognition and protein-nucleic acid mimicry 
The topological nature of RNA and protein are signifi- 
cantly different, and one would expect the structures of 
their normal targets, even the antigen binding sites of anti- 
bodies, to be very different. Indeed, the usual sites or 
motifs for binding of RNA to proteins and proteins to pro- 
teins appear to be very different. Furthermore, the back- 
bone of a nucleic acid is highly charged, whereas that of a 
protein is not charged. As a result, nucleic acids are thought 
to have more difficulty forming globular topologies, a prop- 
erty more characteristic of proteins. Despite these consid- 
erations, the finding that an RNA can mimic a peptide in 
binding to the complementarity-determining regions 
(CDRs), or ligand-binding site, of an antibody [4,7] sug- 
gests that there can be similar chemistry or similar topology 
among these epitopes. Peptides in the range of 10-12 
amino acids may be able to achieve some local conforma- 
tion, while RNA stem-loops of the order of 10 to 12 
nucleotides are sometimes able to form stable tertiary 
structure. In space, approximately three amino acids are 
equivalent to a single nucleotide. Thus, in a topological 
sense, the ability of RNA and protein to fit against a 
common surface is unexpected, but the data of Tsai et al. 
[4] and Doudna etal [7] suggest that it is possible. 
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Figure 4 
Translation components that interact at the 
GTPase center during translocation from the 
A to the P and then to the E site during 
protein synthesis. Regions of transfer RNA (t 
for T stem-loop and a for anticodon stem- 
loop) and ribosomal 28s RNA (r) represent 
RNA conformational epitopes, implicated as 
the sites reactive with autoimmune sera 
[1,8,9] (see Fig. 1). Molecular mimicry may 
exist between the tRNA component of the 
prokaryotic ternary complex (consisting of 
GTP, tRNA and EF-Tu) and EF-G (consisting 
of GTP and EF-G). The eukaryotic analogs of 
EF-TU and EF-G are EF-la and EF-2, 
respectively. Competition between these 
elongation factors for binding to the 
ribosome mediates translocation and the 
hydrolysis of two molecules of GTP during 
translocation. The exact function of the rRNA 
epitope (r) is unknown, but it has been 
shown to have a role at the GTPase center 
during translocation [3,16,24,25]. 
mRNA 
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Both polypeptide and nucleic acid conformations are deter- 
mined by a variety of geometric and steric constraints. 
Hydrogen bonding, hydrophobic considerations and elec- 
trostatic forces are critical in dictating tertiary interactions 
of both kinds of macromolecules. However, there are dis- 
tinct structural differences that affect the folding properties 
of nucleic acids and polypeptides. The high degree of rota- 
tional freedom about six chemical bonds in the RNA back- 
bone is compatible with the formation of multiple 
conformations. It is the highly ordered structure required 
for base pairing that normally constrains the degrees of 
rotation available to RNA (and DNA), and therefore its 
possible conformations. In general, nucleic acids have 
fewer hindrances to torsional freedom of rotation about 
their backbone than peptides, which is compatible with 
greater topological flexibility. Proteins do not form comple- 
mentary base pairs and have fewer conformational possibil- 
ities in the backbone, and have far less complex backbone 
structures than RNA, although they do have the diversity 
provided by the 20 or more possible amino acid side- 
chains. The conformational flexibility available to single- 
stranded nucleic acids in solution is considerable. It is likely 
that this potential for complex shapes and surfaces of RNA 
evolved to fulfill a variety of functional roles in addition to 
catalysis. Ribotopes may represent one such role. 
Antibody CDRs are not necessarily rigid, but can them- 
selves be flexible due to the torsional freedom inherent in 
certain amino-acid sidechains that commonly occur at 
antigen-recognition sites [28]. Thus, molecules that bind to 
the same CDRs are not necessarily molecular mimics of 
one another unless ‘static’ structural features are being rec- 
ognized. Two molecules that recognize the same cellular 
target and have common topologies might also recognize 
the same antibody CDRs even without precise structural 
mimicry. Molecular recognition between topological sur- 
faces is likely to involve dynamic and static properties of 
both the ligand and the target. In cases where suspected 
mimicry involves ligands with distinctive chemical proper- 
ties, such as those of proteins and nucleic acids, competi- 
tive binding to the target is the key feature of common 
function and constitutes a sufficient operational definition 
of mimicry. 
Contrary to some expectations, RNA binding to protein 
can be of higher affinity than protein-protein interactions. 
In addition, it is evident that RNA can acquire many con- 
formational options resulting in a wide biological targeting 
potential [6,29,30]. In v&o RNA selection technologies 
and aptamer experiments have demonstrated that RNA 
has the ability to bind and inhibit enzymes and to disrupt 
protein-protein interactions. It is easy to imagine that 
RNA binding to a protein target ifi viva could displace 
another protein able to bind to the same target surface as 
in the ribotope hypothesis. Likewise, the proteotope and 
the target could be part of the same molecule such that 
the ribotope alters the conformation of the target when 
displacing its mimetic proteotope. 
DNA-protein mimicry 
Although double-stranded DNA is more conformationally 
constrained than either single-stranded DNA or RNA, 
examples of analogous modes of recognition between DNA 
and proteins have emerged. For example, a recent study has 
demonstrated potential molecular mimicry between DNA 
and an enzyme, uracil-DNA glycosylase [31]. This finding 
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resulted from the solution of a crystallized complex 
between the inhibitor of glycosylase and glycosylase itself, 
which showed a twisted five stranded antiparallel P-sheet 
and two ol-helices. In this structural model, the inhibitor 
mimics the DNA-binding groove to which the enzyme nor- 
mally binds. This case, and another example of proteins 
that bind to the DNA-binding globular domains of proteins 
such as histones [32], add to the possible role of mimicry 
between nucleic acids and proteins as a regulatory paradigm 
for biological structure and function. It is relatively straight- 
forward to consider that certain DNA-binding autoantibod- 
ies may originate by crossreactivity between the proteins 
that mimic DNA and DNA. Given that certain DNA- 
binding proteins lack sequence-specific or structure-spe- 
cific recognition, it is expected that antibodies against the 
proteins that mimic the DNA to which they bind might 
themselves have little or no sequence specificity. 
Prejudices against the use of antibodies to precipitate 
DNA and RNA have discouraged investigators from 
testing sera for nucleic-acid-reactive antibodies. It is possi- 
ble that polyclonal antibodies raised in animals against 
viral and cellular proteins will be found to react with spe- 
cific RNA epitopes and thus reveal new ribotopes and 
their crossreactive proteotopes. On the other hand, this 
may be a feature unique to autoantibodies formed in 
response to distinct epitopes [18]. Given the lack of 
research so far in this area, it is possible that ribotopes will 
be discovered in many RNAs and found to be important in 
regulatory processes in the nucleus and cytoplasm. For 
example, ribotopes may be involved in RNA editing, 
telomerase functions, RNA discard and signal recognition. 
Perhaps a better understanding of the regulatory nature of 
ribotopes and proteotopes will provide clues about why 
autoimmune reactivity tends to involve nucleic acids and 
nucleic-acid-associated proteins. 
Do ribotopes exist in viruses? 
Reports of autoantibodies that react with viral RNAs [33] 
have received little attention and probably little investiga- 
tion. On the other hand, many examples of crossreactivity 
between virus proteins and cell proteins have been 
reported ([34] and references therein). The structural sim- 
ilarities between translation elongation factors and tRNAs 
revealed by Nissen et&. [ZO] may relate to the observation 
that many plant and animal viruses contain aminoacylat- 
able tRNA-like structures in their genomes ([35] and ref- 
erences therein). Transfer RNA-like structures present in 
certain plant and animal virus genomic RNAs resemble 
the structures of folded tRNA and may also mimic por- 
tions of EF-2 (EF-G) [21,22]. These genomic tRNA-like 
structures have stem-loops that mimic the anticodon arm 
and the T arm where RNA epitopes have been mapped 
(Fig. 1). Certain picornaviruses are implicated in the auto- 
immune inflammatory muscle disease, myositis (reviewed 
in [36]) and picornaviruses are known to dramatically alter 
translational regulation. As noted above, myositis patients 
contain autoantibodies reactive with aminoacyl-tRNA syn- 
thetases and with tRNA [9,13,15,36]. However, neither 
the mechanisms of translational blockage by viruses, nor 
their role in autoimmunity are well understood. It will be 
interesting to determine whether such viral genomes are 
reactive with autoantibodies. Mimicry could also be affec- 
ted by the presence or absence of modified bases in 
tRNA, which do not seem to be present in the viral tRNA- 
like structures ([35] and references therein). Thus, it re- 
mains to be seen whether viruses contain trans-acting 
RNA structures, which physically displace cellular compo- 
nents at sites where other cell proteins normally interact. 
Do ribotopes exist in messenger RNA? 
Although RNA epitopes were discovered originally in 
small cellular RNAs, their presence in rRNA was detected, 
in part, because of the relative abundance of 1% and 2% 
rRNAs. The low abundance of individual mRNA species 
makes the detection of any RNA epitopes that they may 
contain more difficult. Thus, it is possible that RNA epi- 
topes reactive with antibodies are as common in cellular 
mRNA as in small RNAs and rRNA, but this has not been 
explored. As the untranslated regions of mRNA often have 
significant secondary structure, and presumably possess 
regulatory functions, one might expect trans-active RNA 
structures to reside in 5’- and 3’-UTRs. It has been sug- 
gested that 3’ UTRs may represent Nature’s own combina- 
torial RNA library, allowing the RNA greater plasticity and 
redundancy of sequence with relatively few constraints 
[26]. Recent experiments suggest that trans-acting RNA 
sequences as short as 200 nucleotides can be found in the 
3’-UTRs of cytoskeletal mRNAs that have the unexpected 
property of blocking cell division, causing differentiation 
and suppressing tumor formation [37]. Although the mech- 
anisms of action of these RNA sequences and their respec- 
tive target proteins have not been determined, they may fit 
the ribotope/proteotope model if proteins that bind the 
same targets also exist. Another example of a potential 
trans-acting RNA is the transcription product of the paren- 
tally imprinted mouse H19 locus [38]. This RNA lacks an 
open reading frame, but is the most highly abundant RNA 
in the developing embryo. When expressed transgenically, 
this RNA results in prenatal lethality, indicating its regula- 
tory importance in development. It is reasonable to specu- 
late that this might be a trans-acting RNA with an 
important target molecule. Two other examples of RNA 
transcripts that are involved in genetic imprinting, lack 
open reading frames and may act in trans at target sites to 
affect gene expression include the products of the XIST 
and IPW loci ([39] and references therein). Although there 
is no evidence that these or other trans-acting RNAs can be 
immunogenic and thus be ribotopes, the possibility is 
untested and antibodies are likely to prove highly valuable 
in the discovery of trans-acting RNA species such as these. 
The possibility that antisense transcripts contain ribotopes 
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involved in regulation of gene expression is highly spec- 
ulative, but may help explain the often unpredictable 
functional consequences of antisense RNA expression. 
The area of trans-acting functional RNA is undeveloped, 
but may be stimulated if more investigators test antibodies 
for reactivity with RNA molecules. It is reasonable to 
predict that numerous ribotopes and their corresponding 
proteotopes are waiting to be discovered, and antibody 
reactivity with RNA could represent a valuable method of 
exploration. If, indeed, ribotopes are acting at similar or 
overlapping protein-binding sites on target molecules, it is 
probable that many will prove to be functionally important. 
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